Moderate riskFDA DeviceClass II

Covidien Surgipro sutures recalled over torn sterile packaging

Covidien recalled certain Surgipro SP-623 2-0 blue sutures, lot D6A2963Y, because the sterile packaging may have a tear or hole. This could let germs reach the sutures, which may lead to infection, vision loss if used in eye surgery, or longer surgeries. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Covidien recalls

What to do

  1. Check supplies for Surgipro SP-623, lot D6A2963Y.
  2. Do not use affected sutures.
  3. Contact Covidien or your distributor for return or replacement instructions.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623
Sold in
Nationwide
Made for
All ages (under 100 years)

This recall covers 5 products — see all of them.

Details

Units affected
135,875 total
Illnesses reported
None reported
Manufactured in
60 Middletown Ave, North Haven, CT, United States
Classification
Class II
Recall number
Z-2921-2026

In the FDA's words

Description
Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623 Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery. SP-623 UDI-DI 20884521037073 Lot D6A2963Y Distribution: US Nationwide and the countries of Australia, Austria, Belgium, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guadeloupe, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Kosovo, Lebanon, Lithuania, Luxembourg, Mexico, Namibia, Netherlands, North Macedonia, Northern Ireland, Norway, Oman, Panama, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan. Affected quantity: 135,875 total
Hazard
Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.

5 products in this recall

Covidien surgical sutures recalled for compromised sterile packaging

Covidien is recalling five surgical suture products, including V-Loc 90, V-Loc 180, Dermalon, Surgipro and Surgipro II, with about 135,875 units affected. The sterile packaging may have a tear or hole, which could let germs reach the sutures and cause infection, prolonged surgery, or vision loss if used in eye surgery. The recall covers the US and many other countries, and no injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

SterilityMedical devicesSold nationwideMore from FDA Device